- Home
- FAMI vs ONCO Comparison
FAMI vs ONCO Comparison
Compare FAMI & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- ONCO
- Stock Information
- Founded
- FAMI 2015
- ONCO 2018
- Country
- FAMI China
- ONCO United States
- Employees
- FAMI N/A
- ONCO N/A
- Industry
- FAMI Packaged Foods
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- FAMI Consumer Staples
- ONCO Health Care
- Exchange
- FAMI Nasdaq
- ONCO Nasdaq
- Market Cap
- FAMI 2.1M
- ONCO 1.8M
- IPO Year
- FAMI 2018
- ONCO 2022
- Fundamental
- Price
- FAMI $1.64
- ONCO $0.07
- Analyst Decision
- FAMI
- ONCO
- Analyst Count
- FAMI 0
- ONCO 0
- Target Price
- FAMI N/A
- ONCO N/A
- AVG Volume (30 Days)
- FAMI 96.1K
- ONCO 12.7M
- Earning Date
- FAMI 05-06-2025
- ONCO 05-19-2025
- Dividend Yield
- FAMI N/A
- ONCO N/A
- EPS Growth
- FAMI N/A
- ONCO N/A
- EPS
- FAMI N/A
- ONCO N/A
- Revenue
- FAMI $64,131,332.00
- ONCO $1,870,605.00
- Revenue This Year
- FAMI N/A
- ONCO N/A
- Revenue Next Year
- FAMI N/A
- ONCO N/A
- P/E Ratio
- FAMI N/A
- ONCO N/A
- Revenue Growth
- FAMI N/A
- ONCO N/A
- 52 Week Low
- FAMI $1.43
- ONCO $0.05
- 52 Week High
- FAMI $11.28
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- FAMI 40.76
- ONCO 31.80
- Support Level
- FAMI $1.55
- ONCO $0.05
- Resistance Level
- FAMI $1.98
- ONCO $0.08
- Average True Range (ATR)
- FAMI 0.14
- ONCO 0.01
- MACD
- FAMI 0.05
- ONCO 0.01
- Stochastic Oscillator
- FAMI 29.17
- ONCO 35.54
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.